erythromycin has been researched along with capecitabine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baker, LH; Griffith, KA; Hayes, DF; Rae, JM; Schott, AF; Sterns, V | 1 |
| Gao, M; Johnston, RK; Matthews, AB; Skolnick, J; Snell, TW; Zhou, H | 1 |
1 review(s) available for erythromycin and capecitabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for erythromycin and capecitabine
| Article | Year |
|---|---|
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Breast Neoplasms; Breath Tests; Capecitabine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Deoxycytidine; Erythromycin; Female; Fluorouracil; Genotype; Humans; Maximum Tolerated Dose; Middle Aged; Polymorphism, Restriction Fragment Length; Vinblastine; Vinorelbine | 2006 |
2 other study(ies) available for erythromycin and capecitabine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers.
Topics: Aging; Animals; Capecitabine; Databases, Pharmaceutical; Drug Evaluation, Preclinical; Drug Repositioning; Erythromycin; Female; Genes, Helminth; Glutamates; Healthy Aging; Longevity; Male; Models, Animal; Pravastatin; Reproduction; Rotifera; United States; United States Food and Drug Administration; User-Computer Interface | 2018 |